Gritstone bio, Inc. (GRTS) Tops Q3 EPS by 1c

Gritstone bio, Inc. (NASDAQ: GRTS) reported Q3 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.57 million versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus